A potential disease monitoring and prognostic biomarker in cervical cancer patients: The clinical application of circular RNA_0018289

J Clin Lab Anal. 2020 Aug;34(8):e23340. doi: 10.1002/jcla.23340. Epub 2020 Apr 22.

Abstract

Objective: This study aimed to investigate the tumor circular RNA_0018289 (circ_0018289) expression and its correlation with clinical characteristics as well as survival profiles in cervical cancer patients.

Methods: A hundred and ninety-two cervical cancer patients who received surgical resection were recruited in this prospective study. Tumor tissue and paired adjacent tissue were obtained during the surgery, in which circ_0018289 expression was detected by reverse transcription quantitative polymerase chain reaction. Disease-free survival (DFS) and overall survival (OS) were recorded.

Results: Circ_0018289 expression was upregulated in tumor tissue compared with paired adjacent tissue (P < .001), and receiver operative characteristic curve disclosed its good value for separating tumor tissue from adjacent tissue with an area under curve of 0.907 (95% CI: 0.879-0.935). Additionally, tumor circ_0018289 expression was positively associated with tumor size (P = .009), lymph node metastasis (P = .005) and Federation International of Gynecology and Obstetrics stage (P = .005). The DFS (P = .005) and OS (P = .015) were both worse in patients with circ_0018289 high expression compared to patients with circ_0018289 low expression. Meanwhile, in patients with circ_0018289 high expression, DFS and OS were the longest in patients with high+ expression followed by patients with high++ expression, and the shortest in patients with high+++ expression. Moreover, circ_0018289 high expression could independently predict worse DFS in the total cervical cancer patients (P = .042).

Conclusion: Circ_0018289 could serve as a potential disease monitoring and prognostic biomarker in cervical cancer patients.

Keywords: cervical cancer; circ_0018289; clinical characteristics; survival; tumor tissue.

MeSH terms

  • Adult
  • Biomarkers, Tumor / analysis
  • Biomarkers, Tumor / genetics
  • Cervix Uteri / pathology
  • Female
  • Humans
  • Middle Aged
  • Prognosis
  • Prospective Studies
  • RNA, Circular* / analysis
  • RNA, Circular* / genetics
  • Sensitivity and Specificity
  • Uterine Cervical Neoplasms* / diagnosis
  • Uterine Cervical Neoplasms* / mortality
  • Uterine Cervical Neoplasms* / pathology

Substances

  • Biomarkers, Tumor
  • RNA, Circular